Literature DB >> 23819985

Recent advances in the epidermal growth factor receptor/ligand system biology on skin homeostasis and keratinocyte stem cell regulation.

Daisuke Nanba1, Fujio Toki, Yann Barrandon, Shigeki Higashiyama.   

Abstract

The epidermal growth factor (EGF) receptor/ligand system stimulates multiple pathways of signal transduction, and is activated by various extracellular stimuli and inter-receptor crosstalk signaling. Aberrant activation of EGF receptor (EGFR) signaling is found in many tumor cells, and humanized neutralizing antibodies and synthetic small compounds against EGFR are in clinical use today. However, these drugs are known to cause a variety of skin toxicities such as inflammatory rash, skin dryness, and hair abnormalities. These side effects demonstrate the multiple EGFR-dependent homeostatic functions in human skin. The epidermis and hair follicles are self-renewing tissues, and keratinocyte stem cells are crucial for maintaining these homeostasis. A variety of molecules associated with the EGF receptor/ligand system are involved in epidermal homeostasis and hair follicle development, and the modulation of EGFR signaling impacts the behavior of keratinocyte stem cells. Understanding the roles of the EGF receptor/ligand system in skin homeostasis is an emerging issue in dermatology to improve the current therapy for skin disorders, and the EGFR inhibitor-associated skin toxicities. Besides, controlling of keratinocyte stem cells by modulating the EGF receptor/ligand system assures advances in regenerative medicine of the skin. We present an overview of the recent progress in the field of the EGF receptor/ligand system on skin homeostasis and regulation of keratinocyte stem cells.
Copyright © 2013 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  EGF; EGFR; Growth factor signaling; Keratinocyte stem cells; Keratinocytes

Mesh:

Substances:

Year:  2013        PMID: 23819985     DOI: 10.1016/j.jdermsci.2013.05.009

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  30 in total

Review 1.  Recent advances on the roles of epidermal growth factor receptor in psoriasis.

Authors:  Sijia Wang; Zhuoli Zhang; Han Peng; Kang Zeng
Journal:  Am J Transl Res       Date:  2019-02-15       Impact factor: 4.060

2.  Improved expression of recombinant plant-made hEGF.

Authors:  David Rhys Thomas; Amanda Maree Walmsley
Journal:  Plant Cell Rep       Date:  2014-07-22       Impact factor: 4.570

3.  Heparan sulfate regulates hair follicle and sebaceous gland morphogenesis and homeostasis.

Authors:  Vivien Jane Coulson-Thomas; Tarsis Ferreira Gesteira; Jeffrey Esko; Winston Kao
Journal:  J Biol Chem       Date:  2014-07-22       Impact factor: 5.157

Review 4.  Epidermal growth factor, from gene organization to bedside.

Authors:  Fenghua Zeng; Raymond C Harris
Journal:  Semin Cell Dev Biol       Date:  2014-02-07       Impact factor: 7.727

5.  Cells/colony motion of oral keratinocytes determined by non-invasive and quantitative measurement using optical flow predicts epithelial regenerative capacity.

Authors:  Emi Hoshikawa; Taisuke Sato; Kenta Haga; Ayako Suzuki; Ryota Kobayashi; Koichi Tabeta; Kenji Izumi
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

6.  Growth factors involve in cellular proliferation, differentiation and migration during prostate cancer metastasis.

Authors:  Ilaha Isali; Mohammed Adel Ali Al-Sadawi; Arshna Qureshi; Ahmad O Khalifa; Mukesh K Agrawal; Sanjeev Shukla
Journal:  Int J Cell Biol Physiol       Date:  2019-10-07

7.  Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer.

Authors:  Naoki Takahashi; Yasuhide Yamada; Koh Furuta; Kengo Nagashima; Akiko Kubo; Yusuke Sasaki; Hirokazu Shoji; Yoshitaka Honma; Satoru Iwasa; Natsuko Okita; Atsuo Takashima; Ken Kato; Tetsuya Hamaguchi; Yasuhiro Shimada
Journal:  Cancer Sci       Date:  2015-04-29       Impact factor: 6.716

8.  Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy.

Authors:  Joanne Mortimer; Jae Jung; Yuan Yuan; Laura Kruper; Daphne Stewart; Samuel Chung; Kim Wai Yu; Mary Mendelsohn; Massimo D'Apuzzo; Bernard Tegtmeier; Sanjeet Dadwal
Journal:  Breast Cancer Res Treat       Date:  2014-11-11       Impact factor: 4.872

9.  Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR.

Authors:  Patrick Campbell; Penny E Morton; Takuya Takeichi; Amr Salam; Nerys Roberts; Laura E Proudfoot; Jemima E Mellerio; Kingi Aminu; Cheryl Wellington; Sachin N Patil; Masashi Akiyama; Lu Liu; James R McMillan; Sophia Aristodemou; Akemi Ishida-Yamamoto; Alya Abdul-Wahab; Gabriela Petrof; Kenneth Fong; Sarawin Harnchoowong; Kristina L Stone; John I Harper; W H Irwin McLean; Michael A Simpson; Maddy Parsons; John A McGrath
Journal:  J Invest Dermatol       Date:  2014-04-01       Impact factor: 8.551

10.  YAC tripeptide of epidermal growth factor promotes the proliferation of HaCaT keratinocytes through activation of EGFR.

Authors:  Yeon Ho Yoo; Yu Ri Kim; Min Seo Kim; Kyoung-Jin Lee; Kyeong Han Park; Jang-Hee Hahn
Journal:  BMB Rep       Date:  2014-10       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.